Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

PCOS is a major cause of infertility and requires personalized treatment.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Early hormones shape sex-specific differences in rat glands.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Some men with early hair loss may have a condition similar to PCOS in women.

Homeopathy can help manage PCOS symptoms and improve quality of life.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

SHBG may be a useful early indicator and treatment target for PCOS.